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Abstract 
Background: International rules must be followed for testing biosecurity in dental materials. A new brand of res-
torative material appeared in the market and regulations indicated that it should be tested for toxicity. 
Objectives: The aim of this study was to determine the 90-day sub chronic toxicity of one triethylene glycol dime-
thacrylate containing composite (MEDENTAL Light-Cure Composite™) orally administered to rats according to 
Organization for Economic Co-Operation and Development no. 48 guidelines and the requirements specified in the 
ISO 10993-11. 
Material and Methods: Wistar rats ate the polymerized composite during 90 days and were observed to determine 
changes in their behavior, eye and skin signs and other attitudes such as aggressiveness, posture, walking and res-
ponse to handling. After 90 days were sacrificed to ascertain blood alterations, we did special hematological tests 
and assessed microscopic slides from 33 different organs. 
Results: We recorded no significant changes in clinical behavior of the animals. Microscopic review of the H&E 
stained slides obtained from the analyzed organs showed no abnormal inflammatory or cytological changes and all 
hematological special tests were within normal limits. 
Conclusions: Results of this study show that under our experimental conditions the MEDENTAL Light-Cure Com-
posite™ does not produce inflammatory or cytological changes suggestive of toxicity. 
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Introduction
Since several years ago, different kinds of esthetic dental 
materials exist in the dental market and some of them 
are the reinforced composites that are now considered 
as useful restorative dental materials. However, each 
one has advantages and disadvantages during their use 
as tooth restoration materials (1). Physical-chemical 
properties of these reinforced composites (hardness 
and compressive strength) are the same as conventional 
composites (2) and studies made on different kinds of 
dental composites showed that the most important diffe-
rence among them are: their ability to release fluoride, 
chemical adherence to dentin and compressive strength 
(2,3). Composites are new materials used in Dentistry 
with better physical, chemical, biological, radiological 
and esthetic properties. However, they have some ad-
verse properties as dimensional stress, contraction du-
ring polymerization and cellular damage caused by their 
components (4). 
Recently, polyacid compounds have been added to the 
composites and currently, they have higher viscosity 
and strength resistance (3,5). Chemical composition of 
Article Number: 52201                http://www.medicinaoral.com/odo/indice.htm
© Medicina Oral S. L. C.I.F. B 96689336 - eISSN: 1989-5488
eMail:  jced@jced.es
Indexed in:
Pubmed
Pubmed Central® (PMC)
Scopus
DOI® System
J Clin Exp Dent. 2015;7(2):e289-92.                                                                                                                                                                                      Toxicity of a dental composite
e290
composites is variable and they are composed by one 
organic component bisphenol A-glycidyl methacrylate 
(Bis-GMA) or triethylene glycol dimethacrylate (TE-
GDMA) plus another inorganic component (glass, zir-
conium, barium, quartz and strontium) and a chemical 
bond (silano and polyacid groups). The above-mentio-
ned materials provide reduced contraction properties in 
the finally polymerized composite (2-4). In addition, it is 
known that saliva has a deleterious effect decomposing 
these compounds (6). 
Several studies have been published on TEGDMA ad-
verse effects under different experimental and clinical 
conditions and different parameters were evaluated 
(7-19); also, some reviews were published (8,20). 
It has been demonstrated that TEGDMA induces mito-
chondrial damage and oxidative stress in human gingi-
val fibroblasts and it causes apoptosis in primary human 
gingival fibroblasts (7,9). Other study reported that this 
compound showed a significant enhancement of glucose 
consumption and lactate production inducing GSH de-
pletion and stimulating G6PDH and GR activity (10). 
Studying TEGDMA metabolic effects, Engelmann et 
al. showed it increased the phosphomonoester concen-
tration and decreased the phosphodiesters, enhancing 
the phospholipid turnover. TEGDMA changed the me-
tabolic state of cells indicated by the slight decrease of 
nucleoside triphosphates and increasing the ratio of nu-
cleoside diphosphates to nucleoside triphosphates. The 
most remarkable effect of TEGDMA was a nearly com-
plete decline of intracellular glutathione levels (11). 
Kehe et al. reported that TEGDMA is toxic to pulmo-
nary cells and pointed on the risk for pulmonary cell 
damage (12) and it significantly suppressed TNF-α se-
cretion from THP-1 monocytes stimulated with bacterial 
lipopolysaccharide suggesting that this alteration may 
influence the biological response of tissues to material 
in an inflammatory intraoral environment (13). 
TEGDMA is toxic to human gingival fibroblasts since it al-
ters the mitochondrial dehydrogenase (MTT) and the lacta-
te dehydrogenase (LDH) activities (14). In another report, 
Volk et al. reported that TEGDMA depletes intracellular 
GSH levels at low concentrations suggesting that decrease 
of GSH is an early reaction triggered prior to other cyto-
toxic alterations (15) and Geurtsen et al. (16) found that 
TEGDMA has a very high cytotoxicity potential tested in 
human primary fibroblast cultures. Wataha et al. concluded 
that TEGDMA containing composites affect or alter cellu-
lar functions in Balb/c 3T3 fibroblasts (20). 
Schweikl et al. (17) recently reviewed the genetic toxi-
cology of TEGDMA and Geurtsen and Leyhausen wrote 
on its chemical and biological interactions (8).
There are few reports on skin reactions associated to TE-
GDMA: Kanerva reported on the skin allergic reactions 
to TEGDMA in 8.9% of the patients tested (18) and Kat-
suno et al. demonstrated that three TEGDMA containing 
dentin-bonding systems caused contact dermatitis in the 
skin of guinea pigs (19). Although, the pathogenic me-
chanism is not well known (19,21). 
In view of the above-mentioned results, we tested a 
composite commonly used in private and institutional 
dental practice in Mexico, the MEDENTAL Light-Cure 
Composite™. For this reason, the aim of this study was 
to know the 90-day oral toxicity of a TEGDMA contai-
ning dental composite (MEDENTAL Light-Cure Com-
posite™) orally administered to rats according to OECD 
no. 48 guidelines and the requirements specified in the 
ISO 10993-11 (22,23). 
Material and Methods 
Twenty Wistar rats, were used. 
To perform the current study the recommendations of 
the OECD no. 48 guidelines and the requirements speci-
fied in the ISO 10993-11 were followed (22,23) and the 
protocol for this study was approved by the Ethics Com-
mittee of our institution. following the parameters of the 
above-mentioned documents recommending the use of 
20 rats, we chose ten males and ten females, 9 week old, 
clinically healthy animals weighting 230-250 g. 
TEGDMA containing composite (Light Cure Composite™, 
MEDENTAL Co., Mexico, Distrito Federal, Mexico) was 
prepared without the bonding system following the manu-
facturer instructions. The composite was polymerized with 
a photopolymerizing lamp during 40 sec, pulverized in a 
ceramic mortar and pestle and the pulverized powder was 
stored in sterile Eppendorf tubes. The rats were fed ora-
lly during 90 days with 100μg of the pulverized composite 
every day in the morning and then, they drank water and 
food pellets ad libitum. The rats were observed to determi-
ne changes in eye signs (irritation and inflammation), skin 
and mucous membranes (irritation, inflammation, secre-
tions and pruritus), muck, urine (color, consistency, odor), 
behavior and autonomic activity (aggressiveness, posture, 
walk and response to handling) and other attitudes accor-
ding to ISO 10993-11 regulations (23).  
In day 90, the rats were anesthetized intra-muscularly 
with 2mL of acerpomazine and 1 mL/Kg of ketamine. 
Then, by intracardiac puncture, we obtained 5 mL of 
blood from each rat and stored in EDTA and anticoagu-
lant containing tubes. Rats were sacrificed by aspiration 
of chloroform gas and 33 organs: cerebrum, cerebellum, 
spinal medulla (cervical, mid-thoracic and lumbar), 
pituitary, thyroid, parathyroid, thymus, esophagus, sa-
livary glands, stomach, small intestine, large intestine, 
Peyer’s patches, liver, pancreas, kidney, adrenal, spleen, 
heart, trachea, lung, aorta, gonads (ovaries and testicles), 
prostate, urinary bladder, lymph nodes, peripheral ner-
ves, bone marrow, skin and eyes were immediately im-
mersed in 4% paraformaldehyde during 24 h.  
Specimens were sent to the Clinical and Experimental 
Pathology Laboratory and routinely processed to obtain 
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3µm thick, paraffin embedded, H and E stained slides. 
All the slides were observed in a light transmitted mi-
croscope (Carl Zeiss, Germany) by two experienced 
Oral Pathologists. 
The hematological studies were as follows: hematocrit, 
hemoglobin concentration, erythrocyte count, platelet 
count and total leukocyte count. Laboratory blood tests 
were glucose, urea, creatinine, cholesterol, alanine ami-
notransferase, alkaline phosphatase, total proteins, albu-
min, potassium and sodium blood-concentrations. These 
studies were carried out at the Laboratory of Pathology 
of the Facultad de Veterinaria y Zootecnia, UNAM. Nor-
mal animal values were according to the International 
Species Information System (24). 
Results
After 90 days, the rats gained the normal amount of 
weight. No alterations in the clinical eye signs, skin, mu-
cous membranes, muck, urine, behavior (autonomic ac-
tivity and attitude). During the microscopic analysis of 
the H&E stained slides, no cytological alterations were 
observed in any of the evaluated organs. Although, there 
were minor changes in the hematological tests, but all of 
them were always within normal limits.
Discussion
Several studies on TEGDMA adverse effects have been 
published (7-19), demonstrating that TEGDMA induces 
different metabolic cellular effects as mitochondrial da-
mage, producing depletion of the oxidative stress and 
apoptosis in human gingival fibroblasts altering mito-
chondrial dehydrogenase and lactate dehydrogenase ac-
tivities (7,9,14). Results from other study, showed that it 
significantly enhanced glucose consumption and lactate 
production (10). In the Engelmann et al. study, TEGD-
MA increased the phosphomonoester concentration and 
decreased the phosphodiesters, enhancing the phospho-
lipid turnover. Also, it slight decreased nucleoside tri-
phosphates and increased the nucleoside diphosphates-
nucleoside triphosphates ratio with a nearly complete 
decline of intracellular glutathione levels (11). 
Volk et al. reported that TEGDMA depletes intracellular 
GSH levels at low concentrations suggesting that decrease 
of GSH suggesting it is an early cellular reaction prior to 
other cytotoxic alterations (15) and Wataha et al. conclu-
ded that TEGDMA affect Balb/c 3T3 fibroblasts cellular 
functions (20). The above mentioned results support the 
Geurtsen et al. (16) suggestion that TEGDMA has a very 
high cytotoxicity potential in human fibroblasts.
In 2001, Kehe et al. reported that TEGDMA may influen-
ce the biological response of tissues to material in an 
inflammatory intraoral environment suppressing TNF-α 
secretion from THP-1 monocytes (12) and Schweikl et 
al. (17) reviewed the genetic toxicology of TEGDMA. 
Additionally, there are few reports on skin reactions as-
sociated to TEGDMA (18,19,21). Although, the patho-
genic mechanism is not well known (20,22). 
These results prompted us to test if the commonly used 
restorative material MEDENTAL Light-Cure Composi-
te™ produced clinical or microscopic changes. 
During the study, we found no pathological changes in 
the evaluated parameters. Microscopic review of the 
slides from the 33 selected organs, evidence of infla-
mmatory or pathologic cellular change was not found. 
Results of our study strongly suggest that ingestion of 
the well-polymerized composite we tested (MEDEN-
TAL Light-Cure Composite™) did not produce clinical 
toxicity or behavioral or cytotoxic changes to the studied 
organs of the animals. Results of this study suggest that 
when the clinician uses this resin under the appropriate 
clinical conditions following the manufacturers’ instruc-
tions and the patient inadvertently ingests it, this compo-
site is clinically safe. Under our experimental conditions 
it appears that, “non-polymerized components” of the 
tested composite did not exist or if they are produced, 
their presence during 90 days within the gastrointestinal 
apparatus and their absorption to the blood stream did 
not generate pathologic changes or systemic alterations 
in the studied animals. 
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